Please login to the form below

Not currently logged in

Portfolio Analysis

This page shows the latest Portfolio Analysis news and features for those working in and with pharma, biotech and healthcare.

Latest Intelligence

  • Finance and investment

    Healthcare terms - Finance and investment.

  • Deal Watch March 2017 Deal Watch March 2017

    Sartorius. Acquisition. Platform, instrumentation, software and reagents for real-time live cell analysis. ... 320. Neurovance. Otsuka. Acquisition. Portfolio, including centanafadine in ADHD, with phase II complete.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Portfolio Optimisation: Can you really compare Apples to Oranges?

    Do we really need to review our portfolio of existing or future offerings? ... Black Swan Analysis has proprietary Portfolio Optimisation modelling programmes that are able to accommodate a wide range of assets types, disease areas or type of innovation

  • Portfolio analysis: Making Go/No-Go decisions to optimise the portfolio

    Portfolio analysis: Making Go/No-Go decisions to optimise the portfolio. Tuesday 20th March 2018 11:00 EST / 16:00 GMT / 17:00 CEST. ... conducting portfolio analysis studies.

  • PMRC New Jersey round up 2018

    Tom and Melinda presented the paper, ‘ Portfolio Analysis: Optimizing Communication Approaches for Multiple Assets in a Category’. ... In their presentation they discussed how communications can be optimized in a portfolio, such as when multiple

  • Webinar: Portfolio tracking for success

    Portfolio Analysis and Optimization looks at how honing strategy across multiple agents in the same therapeutic category leads to marketing success. ... series designed to provide clarity when maximizing resources within a category-specific portfolio.

  • Research Partnership

    Research Manager Kayleigh Simpson explores how Key Driver Analysis can be used to answer key business. ... The IBD syndicated market tracker is part of our large auto-immune portfolio.

More from PMHub
Approximately 3 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...